009420 — Hanall Biopharma Share News
0.000.00%
Last trade - 00:00- KR₩2tn
- KR₩2tn
- KR₩155bn
Cullinan Oncology jumps as cancer treatment gets breakthrough therapy tag
Ocugen rises on promising data for COVID-19 vaccine candidate
Ocugen rises on promising data for COVID-19 vaccine candidate
Australia's Neuren Pharma soars on positive phase-3 trials of Rett syndrome treatment
ChemoCentryx up as European drug panel backs rare autoimmune disease drug
NRx Pharma up as FDA completes review on increased shelf life of COVID-19 drug
Bakkt, Redbox, Ocugen shares buoyed by retail chatter
Ocugen jumps on deal with Bharat Biotech and CanSino
Karuna Therapeutics rises as JPM starts coverage with 'overweight' on lead drug potential
Meme stocks rise on final day of quarter
Avidity Biosciences jumps as Evercore starts coverage with 'outperform'
Imago BioSciences rises on update for lead drug studies
Oncology-focused biopharma Immuneering Corp jumps in market debut
Cerevel Therapeutics: Rises on funding for late-stage Parkinson's disease program
Immunome finds antibodies targeting coronavirus variants, shares surge
Gamida Cell: Soars on positive data from late-stage cancer therapy study
Veru Inc: Jumps on positive results from mid-stage COVID-19 drug trial
Australia's Paradigm jumps most in over 4 mths on upbeat knee-pain drug data
Street View: Arcturus's COVID-19 vaccine candidate disappoints in early-stage study